MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-05-03 (fool.com)
This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy |
Medical device specialist Medtronic (MDT 1.38%) has not performed well over the past five years; the stock has significantly lagged broader equities. One of the issues it's encountered is slow revenue growth. Although it explored plans to spin off some of its low-growth units to improve on that front, it eventually abandoned the idea.
Read more
2024-08-07 (mddionline.com)
Tim Walz Has a Track Record of Supporting Medical Device Innovation
Tim Walz, a two-term Minnesota governor, has shown a lot of love for the medical device industry, and medtech innovation.
Read more
2024-02-20 (fiercebiotech.com)
Medtronic reverses patient monitoring spinoff plan, discontinues ventilator sales
More than a year after laying out a plan to divest its pat | More than a year after laying out a plan to divest its patient monitoring and respiratory interventions businesses—sparking months of speculation over potential buyers—Medtronic is reworking the reorganization.
Read more
2023-10-11 (fool.com)
You Can't Control Spin-Offs, but You Can Control What You Do About Them | The Motley Fool
Companies spinning off businesses isn't shocking, but sometimes the benefits of the move aren't quite so clear.
Read more
2023-10-02 (fiercebiotech.com)
Carlyle Group emerges as front-runner in $7B Medtronic spinoff deal: Reuters
Nearly a year after Medtronic announced its intent to spin | Nearly a year after Medtronic announced its intent to spin out its patient monitoring and respiratory interventions divisions, the business units have reportedly found a buyer.
Read more
2023-07-25 (massdevice.com)
Baxter names proposed kidney care spinoff 'Vantive'
Baxter announced today that it picked "Vantive" as the name of its proposed kidney care spinoff.
Read more
2023-06-13 (thewealthadvisor.com)
Private Equity Firms Have $1.5 Trillion to Spend, But Are Struggling to Seal Deals
Private Equity Firms Have $1.5 Trillion to Spend, But Are Struggling to Seal Deals
Read more
2022-12-15 (indiatimes.com)
Siemens Healthineers, GE Healthcare eye Medtronic units, Health News, ET HealthWorld
Medtronic had announced plans in October to spin off the two units - patient monitoring and respiratory interventions - as it seeks to streamline its portfolio. Medtronic is also open to a sale at the right price and the businesses could be valued at more than $7 billion.
Read more
2022-12-15 (indiatimes.com)
Siemens Healthineers, GE Healthcare eye Medtronic units - ET HealthWorld
Medtronic had announced plans in October to spin off the two units - patient monitoring and respiratory interventions - as it seeks to streamline its portfolio. Medtronic is also open to a sale at the right price and the businesses could be valued at more than $7 billion.
Read more
2022-10-24 (healthexec.com)
Medtronic to split patient monitoring and respiratory interventions businesses
Medtronic to split patient monitoring and respiratory interventions businesses Amy Baxter | October 24, 2022 | Leadership Medtronic announced a big spinoff move to separate its combined patient monitoring and respiratory interventions businesses. The
Read more
2022-10-24 (reuters.com)
Medtronic to spin off 2 businesses as part of restructuring process
Medtronic Plc (MDT.N) said on Monday it would spin off two of its smaller businesses into a new company to streamline its portfolio and increase the pace of revenue growth.
Read more
2022-04-05 (massdevice.com)
How Embecta is ‘uniquely positioned’ in diabetes space following spinoff from BD
Nearly one year after BD (NYSE:BDX) announced its intent to spinoff its diabetes business, Embecta (Nasdaq:EMBC) now stands on its own.
Read more